Don't Write Off Immunotherapy in Brain Cancer Just Yet
Researchers should not give up hope in using immunotherapy to treat brain cancers.
Breaking Down Misconceptions About Glioblastoma
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).
Advice for Newly Diagnosed Patients With GBM
David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, offers advice for patients who have recently been diagnosed with glioblastoma (GBM).